Evidence for both innate and acquired mechanisms of protection from Plasmodium falciparum in children with sickle cell trait

Blood

Volumn 119, Issue 16, 2012, Pages 3808-3814

  Gong, Lauren ^a   Maiteki Sebuguzi, Catherine ^b   Rosenthal, Philip J ^c   Hubbard, Alan E ^d   Drakeley, Chris J ^e   Dorsey, Grant ^c   Greenhouse, Bryan ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; CHILD; CLONE; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; GENE; GENOTYPE; GROUPS BY AGE; HETEROZYGOTE; HUMAN; INFECTION RISK; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PARASITEMIA; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL TRAIT; SICKLE HEMOGLOBIN GENE; UGANDA;

EID: 84860327229     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-08-371062     Document Type: Article

References (51)

1. World Health Organization. World Malaria Report: 2010. Available from: http://www.who.int/entity/malaria/world-malaria-report-2010/ worldmalariareport2010.pdf. Accessed April 1, 2011.
2. Ingram V. Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature. 1957;180(4581): 326-328.
3. Gilles HM, Fletcher KA, Hendrickse RG, et al. Glucose-6-phosphate- dehydrogenase deficiency, sickling, and malaria in African children in south western Nigeria. Lancet. 1967;1(7482): 138-140.
4. Aidoo M, Terlouw DJ, Kolczak MS, et al. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet. 2002;359(9314): 1311-1312. (Pubitemid 34310639)
5. Hill AV, Allsopp CE, Kwiatkowski D, et al. Common west African HLA antigens are associated with protection from severe malaria. Nature. 1991;352(6336):595-600. (Pubitemid 21912384)
6. May J, Evans JA, Timmann C, et al. Hemoglobin variants and disease manifestations in severe falciparum malaria. JAMA. 2007;297(20):2220-2226. (Pubitemid 47010879)
7. Jallow M, Teo YY, Small KS, et al. Genome-wide and fine-resolution association analysis of malaria in west Africa. Nat Genet. 2009;41(6):657-665.
8. Piel FB, Patil AP, Howes RE, et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun. 2010;1:104.
9. Williams TN, Mwangi TW, Wambua S, et al. Sickle cell trait and the risk of plasmodium falciparum malaria and other childhood diseases. J Infect Dis. 2005;192(1):178-186. (Pubitemid 40863872)
10. Crompton PD, Traore B, Kayentao K, et al. Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria. J Infect Dis. 2008; 198(9):1265-1275.
11. Clark TD, Greenhouse B, Njama-Meya D, et al. Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda. J Infect Dis. 2008;198(3):393-400.
12. Beet E. Sickle cell disease in the Balovale district of northern Rhodesia. East Afr Med J. 1946;23: 75-86.
13. Haldane JBS. Disease and evolution. Supplement to La Ricera Scientifica. 1949;19:68-76.
14. Allison A. Protection afforded by sickle-cell trait against subtertian malareal infection. Br Med J. 1954;1(4857):290-294.
15. Danquah I, Ziniel P, Eggelte TA, Ehrhardt S, Mockenhaupt FP. Influence of haemoglobins s and c on predominantly asymptomatic plasmodium infections in northern Ghana. Trans R Soc Trop Med Hyg. 2010;104(11):713-719.
16. Roberts DJ, Harris T, Williams T. The influence of inherited traits of malaria infection. In: Bellamy R, ed. The Influence of Inherited Traits on Maleria Infection. Cambridge, United Kingdom: Cambridge University Press; 2004:139-184.
17. Kreuels B, Kreuzberg C, Kobbe R, et al. Differing effects of hbs and hbc traits on uncomplicated falciparum malaria, anemia, and child growth. Blood. 2010;115(22):4551-4558.
18. Mockenhaupt FP, Ehrhardt S, Cramer JP, et al. Hemoglobin c and resistance to severe malaria in ghanaian children. J Infect Dis. 2004;190(5): 1006-1009. (Pubitemid 39120981)
19. Marsh K, Otoo L, Hayes RJ, Carson DC, Greenwood BM. Antibodies to blood stage antigens of plasmodium falciparum in rural gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg. 1989;83(3):293-303. (Pubitemid 19163208)
20. Abu-Zeid YA, Theander TG, Abdulhadi NH, et al. Modulation of the cellular immune response during plasmodium falciparum infections in sickle cell trait individuals. Clin Exp Immunol. 1992; 88(1):112-118.
21. Friedman MJ. Erythrocytic mechanism of sickle cell resistance to malaria. Proc Natl Acad Sci U S A. 1978;75(4):1994-1997. (Pubitemid 8335470)
22. Pasvol G, Weatherall DJ, Wilson RJ. Cellular mechanism for the protective effect of haemoglobin s against P. falciparum malaria. Nature. 1978; 274(5672):701-703. (Pubitemid 8405068)
23. Luzzatto L, Nwachuku-Jarrett ES, Reddy S. Increased sickling of parasitised erythrocytes as mechanism of resistance against malaria in the sickle-cell trait. Lancet. 1970;1(7642):319-321.
24. Williams TN, Mwangi TW, Roberts DJ, et al. An immune basis for malaria protection by the sickle cell trait. PLoS Med. 2005;2(5):e128.
25. Guggenmoos-Holzmann I, Bienzle U, Luzzatto L. Plasmodium falciparum malaria and human red cells. ii. Red cell genetic traits and resistance against malaria. Int J Epidemiol. 1981;10(1):16-22. (Pubitemid 11095376)
26. Cabrera G, Cot M, Migot-Nabias F, et al. The sickle cell trait is associated with enhanced immunoglobulin g antibody responses to plasmodium falciparum variant surface antigens. J Infect Dis. 2005;191(10):1631-1638. (Pubitemid 40656750)
27. Verra F, Simpore J, Warimwe GM, et al. Haemoglobin c and s role in acquired immunity against plasmodium falciparum malaria. PLoS One. 2007;2(10):e978.
28. Clark TD, Njama-Meya D, Nzarubara B, et al. Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of ugandan children. PLoS One. 2010; 5(7):e11759.
29. Dorsey G, Staedke S, Clark TD, et al. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA. 2007;297(20):2210-2219.
30. Davis JC, Clark TD, Kemble SK, et al. Longitudinal study of urban malaria in a cohort of ugandan children: description of study site, census and recruitment. Malar J. 2006;5:18.
31. Gupta V, Dorsey G, Hubbard AE, Rosenthal PJ, Greenhouse B. Gel versus capillary electrophoresis genotyping for categorizing treatment outcomes in two anti-malarial trials in uganda. Malar J. 2010;9:19.
32. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. Pyrimethamine and proguanil resistance-conferring mutations in plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in africa. Am J Trop Med Hyg. 1995;52(6):565-568.
33. Falk N, Maire N, Sama W, et al. Comparison of pcr-rflp and genescan-based genotyping for analyzing infection dynamics of plasmodium falciparum. Am J Trop Med Hyg. 2006;74(6):944-950. (Pubitemid 351627397)
34. Felger I, Schoepflin S, Kiniboro B, Zimmerman PA, Mueller I. Molecular epidemiology of force of infection in malaria [abstract]. Malar J. 2010;9(suppl 2): O14.
35. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121-130.
36. Selvin S. Statistical analysis of epidemiologic data. New York, NY: Oxford University Press; 1996.
37. Mockenhaupt FP, Ehrhardt S, Otchwemah R, et al. Limited influence of haemoglobin variants on plasmodium falciparum msp1 and msp2 alleles in symptomatic malaria. Trans R Soc Trop Med Hyg. 2004;98(5):302-310. (Pubitemid 38950408)
38. Ntoumi F, Rogier C, Dieye A, et al. Imbalanced distribution of plasmodium falciparum msp-1 genotypes related to sickle-cell trait. Mol Med. 1997;3(9):581-592. (Pubitemid 27465229)
39. Konaté L, Zwetyenga J, Rogier C, et al. Variation of plasmodium falciparum msp1 block 2 and msp2 allele prevalence and of infection complexity in two neighbouring senegalese villages with different transmission conditions. Trans R Soc Trop Med Hyg. 1999;93(suppl 1):21-28. (Pubitemid 29123571)
40. Vafa M, Troye-Blomberg M, Anchang J, Garcia A, Migot-Nabias F. Multiplicity of plasmodium falciparum infection in asymptomatic children in senegal: relation to transmission, age and erythrocyte variants. Malar J. 2008;7:17.
41. Roth EF Jr, Friedman M, Ueda Y, et al. Sickling rates of human as red cells infected in vitro with plasmodium falciparum malaria. Science. 1978; 202(4368):650-652. (Pubitemid 9055627)
42. Ayi K, Turrini F, Piga A, Arese P. Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood. 2004; 104(10):3364-3371. (Pubitemid 39507160)
43. Cholera R, Brittain NJ, Gillrie MR, et al. Impaired cytoadherence of plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc Natl Acad Sci U S A. 2008;105(3):991-996. (Pubitemid 351282069)
44. Ockenhouse CF, Shear HL. Malaria-induced lymphokines: stimulation of macrophages for enhanced phagocytosis. Infect Immun. 1983;42(2): 733-739. (Pubitemid 14230273)
45. Ockenhouse CF, Tandon NN, Magowan C, Jamieson GA, Chulay JD. Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor. Science. 1989; 243(4897):1469-1471. (Pubitemid 19087130)
46. McGilvray ID, Serghides L, Kapus A, Rotstein OD, Kain KC. Nonopsonic monocyte/macrophage phagocytosis of plasmodium falciparum-parasitized erythrocytes: a role for cd36 in malarial clearance. Blood. 2000;96(9):3231- 3240.
47. Yazdani SS, Mukherjee P, Chauhan VS, Chitnis CE. Immune responses to asexual blood-stages of malaria parasites. Curr Mol Med. 2006;6(2):187-203.
48. Buffet PA, Safeukui I, Deplaine G, et al. The pathogenesis of plasmodium falciparum malaria in humans: insights from splenic physiology. Blood. 2011;117(2):381-392.
49. Ferreira A, Marguti I, Bechmann I, et al. Sickle hemoglobin confers tolerance to plasmodium infection. Cell. 2011;145(3):398-409.
50. Langhorne J, Ndungu FM, Sponaas A-M, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol. 2008;9(7):725-732. (Pubitemid 351859155)
51. Greenhouse B, Myrick A, Dokomajilar C, et al. Validation of microsatellite markers for use in genotyping polyclonal plasmodium falciparum infections. Am J Trop Med Hyg. 2006;75(5):836-842. (Pubitemid 351627527)